z-logo
open-access-imgOpen Access
The Challenge of Type 1 Diabetes Mellitus
Author(s) -
Larissa Eiselein,
H. J. Schwartz,
James Rutledge
Publication year - 2004
Publication title -
ilar journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.129
H-Index - 75
eISSN - 1930-6180
pISSN - 1084-2020
DOI - 10.1093/ilar.45.3.231
Subject(s) - diabetes mellitus , insulin , medicine , disease , type 2 diabetes mellitus , type 2 diabetes , endocrinology , immunology , bioinformatics , biology
Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom